Emily M Wright1, Areej El-Jawahri2, Jennifer S Temel2, Alaina Carr3, Steven A Safren4, Elyse R Park2, William F Pirl5, Eduardo Bruera6, Lara Traeger7. 1. Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. 2. Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. 3. Department of Psychology, University of Colorado Denver, Denver, Colorado, USA. 4. Department of Psychology, University of Miami, Coral Gables, Florida, USA. 5. Harvard Medical School, Boston, Massachusetts, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA. 6. MD Anderson Cancer Center, Houston, Texas, USA. 7. Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: ltraeger@mgh.harvard.edu.
Abstract
CONTEXT: With increasing attention to the undertreatment of cancer pain in parallel with concerns about opioid misuse, little is known about how patients with advanced cancer adhere to opioid regimens for chronic cancer pain. OBJECTIVES: We explored patient approaches to managing chronic cancer pain with long-acting opioids. METHODS: In a multimethods study at an academic medical center, adult patients with chronic cancer pain (n = 17) used electronic pill caps to record adherence to prescribed long-acting opioid regimens. After eight weeks, patients viewed their adherence records and completed a semistructured interview about their opioid use. With a framework approach, we coded interview data (Kappa >0.95) and identified themes in how patients perceived and used opioids to manage cancer pain. RESULTS: Patients (59% female; 94% non-Hispanic white; median age = 65 years) felt grateful about pain benefit from opioids yet concerned about opioid side effects and addiction/tolerance. Main reasons for nonadherence included both intentional decisions (e.g., skipping doses) and unintentional barriers (e.g., missing doses due to inconsistent sleep schedules). Overall, patients set their own opioid adherence goals and developed routines to achieve them. Residual pain varied and was not consistently linked with opioid adherence. CONCLUSION: Patients commonly felt conflicted about using prescribed long-acting opioids to manage cancer pain due to concurrent perceptions of their risks and benefits, and they set their own parameters for opioid-taking practices. Intentional and unintentional deviations from prescribed opioid schedules highlight the need to enhance adherence communication, education, and counseling, to optimize the use of long-acting opioids as a component of cancer pain management.
CONTEXT: With increasing attention to the undertreatment of cancer pain in parallel with concerns about opioid misuse, little is known about how patients with advanced cancer adhere to opioid regimens for chronic cancer pain. OBJECTIVES: We explored patient approaches to managing chronic cancer pain with long-acting opioids. METHODS: In a multimethods study at an academic medical center, adult patients with chronic cancer pain (n = 17) used electronic pill caps to record adherence to prescribed long-acting opioid regimens. After eight weeks, patients viewed their adherence records and completed a semistructured interview about their opioid use. With a framework approach, we coded interview data (Kappa >0.95) and identified themes in how patients perceived and used opioids to manage cancer pain. RESULTS:Patients (59% female; 94% non-Hispanic white; median age = 65 years) felt grateful about pain benefit from opioids yet concerned about opioid side effects and addiction/tolerance. Main reasons for nonadherence included both intentional decisions (e.g., skipping doses) and unintentional barriers (e.g., missing doses due to inconsistent sleep schedules). Overall, patients set their own opioid adherence goals and developed routines to achieve them. Residual pain varied and was not consistently linked with opioid adherence. CONCLUSION:Patients commonly felt conflicted about using prescribed long-acting opioids to manage cancer pain due to concurrent perceptions of their risks and benefits, and they set their own parameters for opioid-taking practices. Intentional and unintentional deviations from prescribed opioid schedules highlight the need to enhance adherence communication, education, and counseling, to optimize the use of long-acting opioids as a component of cancer pain management.
Authors: Karen L Schumacher; Setsuko Koresawa; Claudia West; Marylin Dodd; Steven M Paul; Debu Tripathy; Peter Koo; Christine Miaskowski Journal: Res Nurs Health Date: 2005-06 Impact factor: 2.228
Authors: Wendy H Oldenmenger; Michael A Echteld; Rianne de Wit; Peter A E Sillevis Smitt; Dirk L Stronks; Gerrit Stoter; Carin C D van der Rijt Journal: J Pain Symptom Manage Date: 2007-08-20 Impact factor: 3.612
Authors: Desiree R Azizoddin; Rosalind Adam; Daniela Kessler; Alexi A Wright; Benjamin Kematick; Clare Sullivan; Haipeng Zhang; Michael J Hassett; Mary E Cooley; Olga Ehrlich; Andrea C Enzinger Journal: Support Care Cancer Date: 2021-03-18 Impact factor: 3.359
Authors: Hester Stoorvogel; Jolanda van Haastregt; Maurice Theunissen; Janna Schoenmaekers; Ann Hoeben; Marieke van den Beuken-van Everdingen Journal: Eur J Cancer Care (Engl) Date: 2022-06-06 Impact factor: 2.328